Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Sleep apnea implants industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Indication trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Sleep Apnea Implant Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2030 (USD Million)
3.3 Industry impact factors
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of obstructive sleep apnea
3.3.1.2 Low compliance & adherence towards CPAP
3.3.1.3 Technological advancements
3.3.1.4 Increasing awareness regarding sleep apnea
3.3.2 Industry pitfalls & challenges
3.3.2.1 High costs of sleep apnea implants
3.3.2.2 Complications associated with sleep apnea implants
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By indication
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Reimbursement landscape
3.8 Pipeline analysis
3.9 Patient journey map
3.10 Porter’s analysis
3.11 Competitive landscape, 2021
3.11.1 Company matrix analysis, 2021
3.12 PESTEL analysis
Chapter 4 Sleep Apnea Implants Market, By Product
4.1 Key segment trends
4.2 Hypoglossal Neurostimulation Devices
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 Market size, by region, 2017 - 2030 (Units)
4.3 Palatal Implants
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2 Market size, by region, 2017 - 2030 (Units)
4.4 Bone screw system
4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.4.2 Market size, by region, 2017 - 2030 (Units)
4.5 Phrenic Nerve Stimulator
4.5.1 Market size, by region, 2017 - 2030 (USD Million)
4.5.2 Market size, by region, 2017 - 2030 (Units)
Chapter 5 Sleep Apnea Implants Market, By Indication
5.1 Key segment trends
5.2 Central sleep apnea
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Obstructive sleep apnea
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Sleep Apnea Implants Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Ambulatory surgical centers
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Sleep Apnea Implants Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2030 (USD Million)
7.2.2 Market size, by country, 2017 - 2030 (Units)
7.2.3 Market size, by product, 2017 - 2030 (USD Million)
7.2.4 Market size, by product, 2017 - 2030 (Units)
7.2.5 Market size, by indication, 2017 - 2030 (USD Million)
7.2.6 Market size, by end-use, 2017 - 2030 (USD Million)
7.2.7 U.S.
7.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.7.2 Market size, by product, 2017 - 2030 (Units)
7.2.7.3 Market size, by indication, 2017 - 2030 (USD Million)
7.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.2.8 Canada
7.2.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.8.2 Market size, by product, 2017 - 2030 (Units)
7.2.8.3 Market size, by indication, 2017 - 2030 (USD Million)
7.2.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2030 (USD Million)
7.3.2 Market size, by country, 2017 - 2030 (Units)
7.3.3 Market size, by product, 2017 - 2030 (USD Million)
7.3.4 Market size, by product, 2017 - 2030 (Units)
7.3.5 Market size, by indication, 2017 - 2030 (USD Million)
7.3.6 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.7 Germany
7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.7.2 Market size, by product, 2017 - 2030 (Units)
7.3.7.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.8 UK
7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.8.2 Market size, by product, 2017 - 2030 (Units)
7.3.8.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.9 France
7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.9.2 Market size, by product, 2017 - 2030 (Units)
7.3.9.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.10 Spain
7.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.10.2 Market size, by product, 2017 - 2030 (Units)
7.3.10.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.11 Italy
7.3.11.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.11.2 Market size, by product, 2017 - 2030 (Units)
7.3.11.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.11.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.12 The Netherlands
7.3.12.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.12.2 Market size, by product, 2017 - 2030 (Units)
7.3.12.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.12.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.13 Switzerland
7.3.13.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.13.2 Market size, by product, 2017 - 2030 (Units)
7.3.13.3 Market size, by indication, 2017 - 2030 (USD Million)
7.3.13.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.4 RoW
7.4.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.2 Market size, by product, 2017 - 2030 (Units)
7.4.3 Market size, by indication, 2017 - 2030 (USD Million)
7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Inspire Medical Systems, Inc.
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Medtronic plc
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Nyxoah SA
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Siesta Medical
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Respicardia, Inc. (Asahi Kasei Company)
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 LivaNova
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
